Founded in 2016, aMoon Fund is a venture capital investment firm based in Ra'anana, Israel. The firm prefers to invest in the early and later-stage companies investing in the health tech and life science sector across the United States, Europe and Israel.
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
MDClone | 01-Mar-2022 | Later Stage VC | 0000 | Medical Records Systems | Generating Revenue | 0000 00000000 00 |
0000000 00000000 | 24-Feb-2022 | 00000 00000 | 00000 | Decision/Risk Analysis | Generating Revenue | |
00000 | 23-Feb-2022 | 00000 00000 | 00000 | Other Healthcare Technology Systems | Generating Revenue | 00000 000000000 00.0 |
00000 000000 | 13-Sep-2021 | 0000 00000 | 000 | Outcome Management (Healthcare) | Generating Revenue | 000 0000000 |
000000 | 20-Jul-2021 | 00000 00000 | 00000 | Drug Discovery | Clinical Trials - Phase 3 | |
00000000 0000000 | 13-Jul-2021 | 00000 00000 | 0000 | Other Devices and Supplies | Generating Revenue | 0000 0000 |
0000 | 16-Jun-2021 | 00 000000000 | 000.00 | Drug Discovery | Generating Revenue | |
0000 00000000000 | 10-May-2021 | 00000 00000 | 00000 | Diagnostic Equipment | Generating Revenue/Not Profitable | |
AltruBio | 15-Apr-2021 | Later Stage VC | 0000 | Drug Discovery | Clinical Trials - Phase 2 | 000 00000000 00 |
Biosplice Therapeutics | 15-Apr-2021 | PE Growth/Expansion | 00000 | Drug Discovery | Generating Revenue | 000 00000000 00 |
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Amylyx | 07-Jan-2022 | IPO | 00000 |
00000.00 | 08-Nov-2021 | 000000000000000000 | 00000 |
000000000 | 01-Nov-2021 | 000000000000000000 | 00000 |
000000 00000000 | 23-Jul-2021 | 000 | 00000 |
0000 00000000000 | 15-Jul-2021 | 000 | 0000 |
0000000 | 24-Feb-2021 | 0000000 000000 | |
0000 | 29-Jan-2021 | 000000 0000000000 | 00000 |
0000 | 04-Dec-2020 | 000 | 00000 |
Adicet Bio | 15-Sep-2020 | Reverse Merger | |
Ayala Pharmaceuticals | 08-May-2020 | IPO | 000.00 |
Investments by Industry
Investments by Year
Investments by Region
PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.
Request a free trialName | Title | Deals | Funds | Boards | Office |
---|---|---|---|---|---|
Irena Katsman | Chief Financial Officer | Ra'anana, Israel | |||
Reut Shema Ph.D | Managing Director | 0 | 0 | Ra'anana, Israel | |
Roy Wiesner | Managing Director | 0 | 0 | 0 | Ra'anana, Israel |
Yair Schindel MD | Co-Founder & Managing Partner | 0 | 0 | 0 | Ra'anana, Israel |
Moshic Mor | General Partner | Ra'anana, Israel |
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Johnson & Johnson Innovation - JJDC | 3 | 0 | 0 | ||
Khosla Ventures | 0 | 0 | 0 | ||
Maverick Capital | 0 | 0 | |||
OrbiMed | 0 | 0 | 0 | ||
The Invus Group | 0 | 0 |